Catch up what you missed in longevity news, anti-aging research, and the fast-growing world of biohacking.
Why your cereal looks like a science experiment (and Europe’s doesn’t).
Grüns hits $500 million valuation, Eli Lilly succeeds once again, and the consumer NAD+ train keeps rolling on. All that and more in this week's edition.
Joe Rogan talks biohacking, wellness retreats are booming, and BJ's protocol is working. All that and more in this week's edition.
Longevity pills for dogs, more bad press for seed oils, and a deep dive into blue zone. All that and more in this week's edition.
Fluoride debate goes mainstream & sea-salt for anti-aging. All that and more in this week's edition.
Jump training, 23andMe goes bankrupt, and a deep dive on NAD+. All that and more in this week's edition.
Lion's mane, NAD+ infusions, and racquet sports. All that and more in this week's edition.
VO2 Max, "zombie cells" and event season is just heating up. All that and more in this week's edition.
